Eriochem
Manufacturing · Argentina · 201-500 Employees
View Company Info for Free
Overview
Headquarters
452 Ruta 12 Km, Colonia Avellaneda, Entr...Phone Number
+54 3434979125Website
www.eriochem.com.arRevenue
$22.4 MillionIndustry
About Eriochem
Eriochem Org Chart
Is Eriochem your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Eriochem is spiking on competitors!
Click to see if Eriochem had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Eriochem, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Eriochem has new funding data
Check if Eriochem has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Eriochem
Product Launch: Get notified when Eriochem launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Eriochem recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Eriochem is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eriochem is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eriochem.
Eriochem Tech Stack
A closer look at the technologies used by Eriochem
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Eriochem
ERIOCHEM S.A. is an Argentine pharmaceutical laboratory focused on the development and manufacturing of high-quality oncology generics and value-added medications. The company aims to produce international quality generics while maintaining competitive pricing to enhance treatment accessibility for doctors and patients. With a strong emphasis on re... Read More